Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae

Clinical trial NCT03891433 · SUSPENDED

Trial details

NCT number: NCT03891433
Sponsor: Universidad del Norte
Status: SUSPENDED
Phase: Phase 4
Study type: INTERVENTIONAL

Urinary Tract Infections Enterobacteriaceae Infections Infection Due to ESBL Bacteria Carbapenem Escherichia Coli Infection Klebsiella Pneumoniae Infection Clinical Trial Drug Resistance, Bacterial

Start date: 2019-04-01
Primary completion: 2024-12-01
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.